Stella Diagnostics, Inc. (SLDX)
0.0081
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Stella Diagnostics Shareholders Equity (Quarterly) : -28.94M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.94M |
| March 31, 2026 | -27.97M |
| December 31, 2025 | -26.88M |
| September 30, 2025 | -25.28M |
| June 30, 2025 | -23.24M |
| March 31, 2025 | -19.42M |
| December 31, 2024 | -18.77M |
| September 30, 2024 | -18.54M |
| June 30, 2024 | -18.26M |
| March 31, 2024 | -17.84M |
| December 31, 2023 | -17.53M |
| September 30, 2023 | -16.42M |
| June 30, 2023 | -15.61M |
| March 31, 2023 | -15.22M |
| December 31, 2022 | -22.04M |
| September 30, 2022 | -217.25M |
| June 30, 2022 | -216.51M |
| March 31, 2022 | -217.23M |
| December 31, 2021 | |
| September 30, 2021 | -11.42M |
| June 30, 2021 | -11.23M |
| March 31, 2021 | -11.09M |
| December 31, 2020 | |
| September 30, 2020 | -6.519M |
| June 30, 2020 | -6.485M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.604M |
| December 31, 2019 | -5.601M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -0.6135M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | -0.3986M |
| June 30, 2016 | -0.3986M |
| March 31, 2016 | -0.3934M |
| December 31, 2015 | |
| September 30, 2015 | 1.307M |
| June 30, 2015 | -0.473M |
| March 31, 2015 | -0.4234M |
| December 31, 2014 | -0.3901M |
| September 30, 2014 | -0.2689M |
| June 30, 2014 | -0.2652M |
| March 31, 2014 | -0.2567M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.3419M |
| Xcelerate, Inc. | -2.102M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.4448M |
| Vivos Therapeutics, Inc. | -3.815M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1132M |
| Total Liabilities (Quarterly) | 29.06M |
| Debt to Equity Ratio | -0.4877 |
| Current Ratio | 0.0023 |
| Net Debt Paydown Yield | -45.99% |